Related by context. All words. (Click for frequent words.) 72 preclinical 72 GLP toxicology studies 70 IND submission 68 IND enabling 68 preclinical efficacy 68 Protexia ® 68 cGMP manufacture 67 GLP toxicology 66 synDNA TM 66 rxRNA 66 Protexia R 66 Thorough QT 65 therapeutic monoclonal antibodies 65 Phase Ib study 65 OvaRex R 65 Phase 2a clinical trials 65 Prodarsan ® 65 Anthim 65 trastuzumab DM1 T DM1 65 BLA filing 65 PEGPH# 64 Prodarsan R 64 SparVax TM 64 peptide synthesis 64 oral prodrug 64 Factor VIIa 64 midstage clinical 64 Curaxin 64 Aurora kinase inhibitor 64 Phase IIb clinical trials 64 Stimuvax R 64 pharmacokinetic studies 64 rPA anthrax vaccine 64 Phase Ib II 63 XOMA 3AB 63 RiVax 63 IMA# 63 PSMA ADC 63 ADME 63 GRNVAC1 63 Exherin TM 63 Phase IIB 63 elotuzumab 63 DXL# 63 trodusquemine 63 ONCONASE R 63 IMC #B 63 Nonclinical 63 midstage trials 63 glucokinase activator 63 Cloretazine ® 63 bardoxolone 63 SparVax ™ 63 CEQ# 63 non nucleoside HCV 63 vivo validation 63 ASONEP 63 Immunotherapeutic 63 Pharmos pipeline 63 CD# CEA 63 AMPAKINE CX# 63 RAV# 63 pivotal bioequivalence 63 Valortim R 63 lomitapide 63 Archexin 62 CellCiphr 62 Phase IIa trials 62 Phase #b/#a 62 Phase Ib clinical 62 PLK1 SNALP 62 JAK inhibitor 62 Onconase 62 candidate CRLX# 62 clinical pharmacology studies 62 PEG SN# 62 Surfaxin LS 62 phase IIb clinical 62 R#/MEM # 62 therapeutic monoclonal antibody 62 Azedra 62 Phase 2a trial 62 CCX# 62 preclinical studies 62 Aerosurf 62 PREOS R 62 histone deacetylase inhibitor 62 Phase 1a clinical 62 nalbuphine ER 62 ApoB SNALP 62 vivo preclinical 62 PDE4 inhibitor 62 tiapamil 62 PRT# 62 HGS# 62 atacicept 62 targeted radiotherapeutic 62 deCODE chemistry 62 tolevamer 62 EndoTAG TM -1 61 Kahalalide F 61 faropenem 61 MEK inhibitor 61 vitro ADME 61 Phase Ia 61 EV# vaccine 61 OncoVEX GM CSF 61 NEUMUNE 61 Symadex 61 AeroLEF TM 61 PhG alpha 1 61 phase IIb 61 immunotherapeutic vaccine 61 Spiegelmer ® 61 YONDELIS 61 SinuNase ™ 61 Lisofylline LSF 61 CRLX# 61 Preclinical 61 Androxal TM 61 phase IIa clinical 61 mertansine 61 PDE# inhibitors 61 carcinogenicity study 61 Azedra ™ 61 Phase IIa clinical trials 61 bioscavenger 61 rhMBL 61 proteasome inhibitor 61 Tesmilifene 61 TACI Ig 61 IIa clinical 61 Homspera 61 ENMD # 61 Oligonucleotide 61 Proellex TM 61 HQK 61 Urocidin 61 HCV protease inhibitor 61 RenaZorb TM 61 TKM Ebola 61 Neuradiab 61 siRNA therapeutics 61 inhalation toxicology 61 phase IIa 61 Systemic Delivery 61 HspE7 61 drug GAP #B# 61 Actilon 61 dacetuzumab 61 indibulin 61 ATL# [001] 61 TBC# 61 vivo pharmacology 61 Drug Repositioning 61 MOR# 61 Zalypsis 61 ALN TTR# 61 tramiprosate Alzhemed TM 61 Glybera R 61 Dalbavancin 61 telomerase therapeutic 61 OHR/AVR# 61 Myocet 61 BioVant 61 liprotamase 61 Protectan CBLB# 61 Mipomersen 60 investigational humanized monoclonal antibody 60 KNS # 60 clinical trials 60 GAP #B# 60 Valortim 60 IND Investigational New 60 pharmacokinetic PK study 60 CRD5 60 anti CD3 monoclonal 60 TRV# [001] 60 Solazed 60 UPLYSO 60 Azedra TM 60 AQ4N 60 Zemiva TM 60 nonclinical studies 60 MOZOBIL 60 vivo toxicology 60 lenalidomide Revlimid R 60 IL# PE#QQR 60 compound AEOL # 60 triphendiol 60 preclinical pharmacology 60 Sym# 60 Valortim TM 60 recombinant biopharmaceutical 60 Menerba 60 LentiVector technology 60 apricitabine ATC 60 enzastaurin 60 BioNumerik 60 Dextofisopam 60 GeoVax vaccine 60 Scil Proteins 60 bortezomib Velcade 60 Trofex TM 60 Virulizin 60 Allovectin 7 60 Cethrin R 60 ONCONASE 60 ART# 60 XL# XL# 60 HDL Mimetic Peptide 60 HCV polymerase inhibitor 60 MAXY VII 60 ANAVEX #-# [001] 60 REP# 60 PNT# 60 ANAVEX #-# [003] 60 ORENCIA R 60 PhaseBio 60 biodistribution studies 60 Phase 2b study 60 ALN TTR 60 BCX# 60 MAXY G# 60 CBLC# 60 Omacetaxine 60 Small Molecule 60 OvaRex ® MAb 60 AEG# 60 RNAi Therapeutic 60 eTag assays 60 ALN VSP 60 ALN PCS 60 PANVAC VF 60 recombinant antibodies 60 BrachySil 60 Xanafide 60 bioequivalence studies 60 Panzem 60 PRX# 60 thorough QT 60 CytoFabTM 60 Civacir 60 epigenetic therapies 60 NTDDS 60 NovaBay Aganocide compounds 60 Cutanea 60 nucleoside tide 60 Shigamabs R 60 Phase Ib 59 HIV integrase inhibitor 59 Panzem R NCD 59 Ramoplanin 59 riociguat 59 GSK# [002] 59 phase Ib 59 orally dosed 59 Lixivaptan 59 cMET 59 Charlesson 59 Pimavanserin 59 LungExpress Dx TM 59 ISIS # 59 Phase IIa clinical 59 depsipeptide 59 Max Neeman International 59 novel peptides 59 Exelixis compounds 59 Phase IIa trial 59 PER.C6 ® cell 59 rBChE 59 ganetespib 59 PRLX # 59 nanoviricides 59 Sopherion 59 Guanilib 59 NDA resubmission 59 pharmacokinetic pharmacodynamic 59 Trofex 59 EGEN 59 Anticalin ® 59 PrevOnco 59 FluCide 59 Neo Kidney Augment 59 Virulizin ® 59 next generation URAT1 59 CB2 selective receptor agonist 59 Lovaxin C 59 phase Ib clinical 59 Valdoxan 59 Phase lll 59 NPC 1C 59 Phase IIIb clinical 59 Lpathomab 59 NP2 Enkephalin 59 ATL# [002] 59 PRESEPT study 59 Tesetaxel 59 OncoVEX 59 biologic therapeutics 59 Dacogen injection 59 MEK inhibitor RDEA# 59 antisense drug 59 selective androgen receptor modulator 59 TRO# 59 Phase III clinical 59 ADME Tox 59 solithromycin 59 HGS ETR2 59 Alzhemed TM 59 acyclovir Lauriad R 59 AVN# [001] 59 AMPK activators 59 Urocidin TM 59 cannabinor 59 UVIDEM 59 THR beta agonist 59 inhaled AAT 59 oral antiviral 59 Fodosine 59 Phase IIa 59 OraTest R 59 NEUGENE antisense 59 Valortim ® 59 biomarker identification 59 SGLT Inhibitors 59 Nasdaq IDRA today 59 JAK2 inhibitor 59 Ostarine 59 ZFN modified 59 GGF2 59 dextofisopam 59 PSN# [002] 59 preclinical pharmacokinetic 59 Phase 2b clinical trials 59 DPX Survivac 59 HCV polymerase 59 Vaxfectin R formulated 59 LymphoStat B TM 59 NEUGENE R 59 midstage studies 59 Fibrillex TM 59 Radilex 59 antitumoral 59 Phase IIb III 59 ImQuest 59 A5 Labs 59 DermTech International 59 JAK3 59 SUCCEED trial 59 SILENOR 59 Aplidin 59 CBLB# 59 SNALP technology 59 seliciclib CYC# 59 RSD# oral 59 HuMax EGFr 59 PROSTVAC TM 59 ThermoDox ® clinical 59 RNAi therapeutic targeting 59 HepaGam B 59 EHT AGN 59 JAK inhibitors 59 HDAC Inhibitor 59 Fentanyl TAIFUN R 59 Velcade bortezomib 59 pafuramidine 59 PHX# 59 HGS ETR1 59 radiotherapeutic 59 Cleviprex TM clevidipine 59 protein biomarker discovery 59 NNR Therapeutics 59 metabolite identification 59 Pancreate 59 siRNA therapeutic 59 H#N# VLP vaccine 59 Aurexis 59 Alocrest 59 Kevetrin 59 Phase 2a clinical 59 Solazed TM 59 Novolimus 59 TKM ApoB 59 multicenter Phase II 59 GLPG# 58 Phase #/#a trial 58 Neo Kidney Augment ™ 58 PD LID 58 EGS# 58 INCB# [001] 58 Saforis 58 Phase IIb trials 58 tkRNAi 58 BNC# 58 VersaFilm 58 adrenergic regulation 58 pradefovir 58 BAL# [002] 58 vosaroxin 58 CORT # 58 humanized antibodies 58 Maribavir 58 antibody MAb 58 epothilone 58 eniluracil 58 Chemokine Therapeutics 58 Xcytrin R 58 EVIZON TM 58 Investigational 58 generation URAT1 inhibitor 58 outlicensed 58 MKC# MKC# PP 58 QLT# 58 polyclonal antibody 58 XL# XL# XL# XL# 58 Urocortin 2 58 XmAb# 58 GPR# agonist 58 Phase Ib clinical trials 58 RGB # 58 Onco TCS 58 Onalta 58 Vaxfectin TM 58 including eniluracil ADH 58 Aurora Kinase 58 Initiates Clinical 58 Anavex #-# 58 PharmaNova 58 ActivX 58 Rigel R# 58 huC# DM4 58 MediVas 58 Dyloject TM 58 vascular disrupting agents 58 CYT# potent vascular disrupting 58 radiolabeling 58 BrachySil TM 58 tubulin inhibitor 58 MAXY alpha 58 Fx #A 58 Sulonex 58 Kevetrin ™ 58 BACcel 58 TLR antagonists 58 novel peptide 58 CAMPATH 58 MEK inhibitors 58 DispersinB R 58 Lenocta 58 ospemifene 58 mitogen activated ERK kinase 58 Phase IIb 58 Bicifadine 58 REG1 58 Phase 1b clinical trials 58 Intarcia 58 afamelanotide 58 Hedgehog antagonist 58 Aganocide 58 IRX 2 58 Plicera 58 Pharma Medica 58 ocular formulation 58 Pharmos proprietary 58 biased ligand 58 rPA 58 Urokinase 58 non nucleoside inhibitor 58 oncolytic virus therapies 58 investigational HCV polymerase 58 MVA BN R 58 romidepsin novel 58 Homspera TM 58 DOS# 58 therapeutic mAbs 58 Chiral Quest 58 velafermin 58 Aquinox 58 Allovectin 7 r 58 candidate TNFerade biologic 58 Adnectin 58 Tarvacin TM 58 CCR5 mAb 58 thymalfasin 58 aurora kinase 58 Hematide ™ 58 Litx 58 Elagolix 58 RhuDex ® 58 selective androgen receptor modulators 58 Phase III clinical trials 58 Galenea 58 Cytotoxic 58 farletuzumab 58 vitro experiments 58 oncolytic virus therapy 58 Phase 2b 58 SynCon 58 Cerashield 58 Laureate Pharma 58 torezolid phosphate 58 JOULFERON 58 MGd 58 Nanobody ® 58 Corlux 58 AP# [003] 58 predictive toxicology 58 Phase 2b clinical 58 TriRima 58 favorable pharmacokinetic profile 58 SILENOR TM 58 VNP#M 58 Preclinical studies suggest 58 Amigal 58 TELINTRA 58 maturation inhibitor 58 Technosphere Insulin 58 biomarker discovery validation 58 #D#C# 58 outlicensing 58 Evotec OAI 58 hematological tumors 58 Monoclonal Antibody 58 DMPK 58 PK PD 58 HuLuc# 58 nicotinic alpha 7 58 GALNS 58 Nanobodies ® 58 CGEN # 58 epothilones 58 Cenomed 58 TOCOSOL Camptothecin 58 Prodarsan 58 biomarker discovery 58 TLK# 58 OncoVex 58 AKT inhibitor 58 cathepsin K inhibitor 58 Phase III Pivotal 58 Hyphanox 58 novel VDA molecule 58 StaphVAX R 58 NITD# 58 SMT C# 58 confirmatory clinical 58 Trastuzumab DM1 58 RIGScan CR 58 Talotrexin 58 HCD# [002] 58 synthetic retinoid 58 DeveloGen 58 Tandem Labs 58 delipidation 58 romazarit 58 PrevOnco ™ 58 cancer immunotherapies 58 GED aPC 58 Bioanalytical 58 ELACYT 58 CG# [003] 58 Bexion 58 alvespimycin 58 pomalidomide 58 immatics 58 HCV antiviral 58 RhuDex 58 Taligen Therapeutics 58 ELND-#/AZD-# 58 BioMarck 58 metaglidasen 58 PXD# 57 VLP vaccine 57 Traficet EN 57 RhuDex R 57 antisense inhibitors 57 oral taxane 57 incyclinide 57 LEAD Therapeutics 57 ToxCast TM 57 human microdosing 57 Chimigen TM 57 Squalamine 57 Sutent sunitinib 57 carcinogenicity studies 57 staphylococcal vaccine 57 LB# [003] 57 P#X# antagonist 57 ZEVALIN ® 57 PCK# 57 PORxin TM platforms 57 ICA # 57 potent suppressor 57 ESBA# 57 AERx ® 57 oral methylnaltrexone 57 ADVANCE PD 57 AZX# Phase 57 AERx iDMS 57 Curaxin CBLC# 57 preclinically 57 Cathepsin S 57 isavuconazole 57 defensin mimetic antibiotic 57 MAGE A3 ASCI 57 Nektar pulmonary 57 TKM PLK1 57 DEB# 57 NASDAQ CGEN announced 57 Iloperidone 57 thalidomide Thalomid 57 Bioral Amphotericin B 57 fidaxomicin Phase 3 57 oral picoplatin 57 Targeted Chemotherapy 57 INT# [002] 57 phase IIb trial 57 rindopepimut 57 demonstrated antitumor activity 57 PREOS 57 Chrysalin 57 Protexia 57 AnGes MG Inc. 57 indiplon capsules 57 FOLOTYN ® 57 Phase #b/#a trial 57 novel anticancer 57 Chemokine 57 successfully commercialize Iluvien 57 initiate multicenter 57 Enzyme Replacement Therapy 57 Lymphoseek ® 57 myelofibrosis polycythemia vera 57 Virulizin R 57 SmartChip TM Real 57 mGluR5 NAM 57 Carfilzomib 57 SNS# T 57 leading oral taxane 57 confirmatory Phase 3 57 BLA submission 57 clinical trial 57 Kosan dependence 57 Triapine R 57 VEGF Trap 57 PEGylated interferon 57 FluBlok 57 Personalized Immunotherapy 57 alpha#beta# integrin 57 Cloretazine R VNP#M 57 MCSP respectively 57 NS5A 57 Panzem R 57 AdhTAP 57 systemic RNAi 57 L DOS# 57 ALTU 57 Phase 1a 57 GRNCM1 57 OMP #M# 57 immune modulatory 57 mAbs 57 Cetrorelix 57 mGluR2 NAM 57 Bio Quant 57 synthetic nucleic acid 57 ALISTA 57 PSN# [001] 57 Pharmacodynamic 57 vinca alkaloid 57 ACV1 57 HCV protease inhibitors 57 Phase 2a 57 Primera Bioscience 57 personalized immunotherapy 57 CIP TRAMADOL ER 57 HuCAL antibodies 57 Protexia TM 57 GeneICE 57 GSK # 57 RayBiotech 57 Alvesco R 57 investigational hepatitis B 57 Enobia 57 alemtuzumab MS 57 BRIM3 57 Vaxfectin 57 methylnaltrexone 57 ISTODAX 57 butyrylcholinesterase 57 Phase III Clinical Trial 57 vivo efficacy 57 cartilage regeneration 57 Confirmatory 57 Cloretazine R 57 masitinib 57 SURFAXIN 57 Trofex ™ 57 SNT MC# 57 budesonide foam 57 Hepatitis C HCV 57 TRAIL receptor antibodies 57 Aflibercept 57 AKIP 57 Recombinant Human 57 Phenoptin 57 albiglutide 57 velafermin belinostat 57 ALN HTT 57 AEOL # 57 rhThrombin 57 TRX1 57 LibiGel ® 57 EP #R 57 Sulonex TM 57 Alferon N 57 liposomal formulation 57 immune modulating 57 Soliris eculizumab 57 GTC recombinant human 57 Vaccinex 57 polyclonal antibodies 57 Onalta ™ 57 Onalta TM 57 Interferon Gamma 57 raxibacumab 57 Pivotal Phase III 57 ASPIRE HIGHER 57 ALK inhibitors 57 volociximab 57 Bendamustine 57 TBC M4 57 Avid Bioservices 57 histone deacetylase HDAC inhibitor 57 Proxinium TM 57 rhLF 57 Vitaxin 57 Pentad TM 57 BrachySil ™ 57 Zemplar Capsules 57 Rosetta Genomics microRNA 57 Ketotransdel 57 kidney urologic 57 Bellicum Pharmaceuticals Inc. 57 eprotirome 57 DiaKine 57 MYDICAR ® 57 ATL/TV# 57 microdosing studies 57 apoptosis inducer 57 HDACi 57 Vidofludimus 57 Shigamabs 57 TriGrid 57 APF# 57 Pertuzumab 57 nucleotide analog 57 Novel Antibiotic 57 G#DT 57 anticoagulant reversing agent 57 CD# monoclonal antibody 57 Shigamabs ® 57 FluINsure 57 ZFP Therapeutic 57 MGCD# [001] 57 NEUGENE 57 Hybridon 57 Triolex 57 dose escalation Phase 57 Liprostin 57 BLP# Liposome Vaccine 57 Bayer HealthCare Onyx Pharmaceuticals 57 nitric oxide donating prostaglandin 57 Poly ICR 57 Syntonix 57 Cethromycin 57 immunotoxins 57 Anidulafungin 57 danoprevir 57 bovine thrombin 57 novel histone deacetylase 57 DGAT 57 Zybrestat 57 small molecule agonists 57 Synavive 57 PhytoMedical 57 rALLy 57 Uvidem 57 GelSite polymer 57 Anticalins R 57 investigational monoclonal antibody 57 Celator 57 Selexis 57 Universal Flu Vaccine 57 Ampligen ® 57 confirmatory Phase III 57 DiLA2 57 SIRT1 activators 57 Acute Radiation Syndrome ARS 57 Bezielle 57 Pruvel 57 sitaxsentan 57 Cerashield ™ 57 FDA Approvable Letter 57 tremelimumab 57 Phase III 57 Davanat 57 Thiovir 57 Vaxfectin R adjuvant 57 cardio renal 57 RNAi Therapeutics 57 Therapeutic Vaccine 57 Cellerant 57 bosutinib 57 PORxin TM 57 anticancer agent 57 Nasdaq HALO 57 Nasdaq RDEA 57 reslizumab 57 torsemide ER 57 Novasome R 57 candidate REP# 57 therapeutic peptide 57 BiTE antibody 56 isoform selective 56 CR# vcMMAE 56 molecular imaging radiopharmaceutical 56 Dapagliflozin 56 NEUVENGE 56 Darinaparsin 56 Cloretazine 56 Juvaris 56 ulimorelin 56 Annamycin 56 clevudine 56 ThermoDox R 56 EOquin 56 Genasense R oblimersen 56 VA# [002] 56 uricase 56 vaginally administered lidocaine 56 hematological cancers 56 ROTARIX 56 LC#m# 56 superior bioprocessing 56 gefitinib Iressa 56 product platforms AZX# 56 Cannabinor 56 telomerase inhibitor drug 56 vismodegib 56 BioFocus DPI Galapagos 56 proprietary PEGylation 56 Asentar 56 R roscovitine 56 Bionutrics 56 CINTREDEKIN BESUDOTOX 56 Phase #/#a 56 KRN# 56 PF # [002] 56 CCR9 antagonist 56 TSX VENTURE SVA 56 Prostate AdenoCarcinoma Treatment 56 Cytolin 56 Ore Pharmaceuticals 56 DB# [003] 56 Organichem 56 NeuVax 56 RNAi therapeutic 56 MEK Inhibitor 56 NABTT 56 orally bioavailable 56 WILEX 56 TOCOSOL Paclitaxel 56 dirucotide 56 MAb 56 Medical Countermeasure 56 Elusys 56 clinical 56 GeoVax AIDS vaccine 56 DispersinB ® 56 tesmilifene 56 ongoing Phase IIIb 56 XmAb 56 Nasdaq IDRA 56 HemoTech TM 56 tezampanel NGX# 56 Flutiform TM 56 Phase IIb Clinical Trial 56 Quark Biotech Inc. 56 recombinant polyclonal antibody 56 Imvamune R 56 ProLindac 56 EVIZON TM squalamine lactate 56 figitumumab 56 novel therapeutic antibodies 56 molecular imaging radiopharmaceuticals 56 research anddevelopment 56 histone deacetylase HDAC 56 talactoferrin 56 Selective Electrochemical Tumor Ablation 56 lipid nanoparticle 56 proprietary LNA 56 Azopharma 56 EXPAREL ™ 56 PET tracers 56 Phase 1b 56 Gleevec resistant 56 registrational trial 56 Vion Pharmaceuticals 56 Gastrotech 56 Zemiva ™ 56 Fc fusion protein 56 APEX PD 56 Glufosfamide 56 REGN# 56 DermaVir 56 lumiliximab 56 RECOTHROM R 56 generation antisense 56 serine protease inhibitor CU# 56 huN# DM1 56 Idera Pharmaceuticals 56 ICH guidelines 56 tasimelteon 56 trastuzumab DM1 56 entity NCE 56 CDP# 56 Desmoteplase 56 L BLP# 56 Cardio Vascu Grow 56 Omthera 56 protein homeostasis 56 AAG geldanamycin analog 56 Aganocide ® 56 ORE# 56 EDEMA3 trial 56 FoldRx 56 NYSE Amex PTN 56 NXL# 56 Allovectin 7 R 56 DepoVax TM 56 Ocrelizumab 56 fosbretabulin 56 rNAPc2 56 Marqibo TM 56 MORAb 56 ELND# 56 Phase #b/#a clinical 56 Regeneron Pharma 56 MKC# MT 56 denosumab oncology 56 Wellstat 56 Octreotide 56 E1 INT TM 56 XP# XP# 56 CHAMPION PCI 56 YONDELIS R 56 LEAPS TM 56 mechanistic insights 56 TransVax ™ 56 TransVax TM 56 OXi# 56 acyclovir Lauriad ® 56 MEND CABG 56 TELCYTA 56 telaprevir VX 56 oral PTH 56 Romidepsin 56 midstage clinical trials 56 Alinia 56 mda 7 56 Zenvia Phase III 56 PS# [001] 56 OTCBB PYTO 56 histone deacetylase HDAC inhibitors 56 ALTROPANE R 56 NO# [002] 56 HCV polymerase inhibitors 56 CCR5 inhibitor 56 JAK2 inhibitors 56 EndoTAG TM 56 Oncaspar 56 flavopiridol 56 oral gallium 56 Ultrafast Insulin 56 OLpur TM H2H 56 Nasdaq CGEN 56 PNP inhibitor 56 LibiGel Phase III 56 PEARL SC 56 Altastaph 56 Anticalins ® 56 nanomedicines 56 BEXXAR 56 Ceflatonin R 56 NanoViricides 56 teduglutide 56 SinuNase TM